Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • “And The Oats” the revolutionary skincare brand by Skin Care Expert Inderjeet Kaur ‘Indy’ Business
  • Interview with Advocate Anik: Supreme Court’s Landmark Ruling and Protection of OCI Rights Business
  • Indus University Concludes its 7th convocation Ceremony Press Release
  • The Non Surgical Hair Growth Solution By Dr Stuti Khare Shukla Changing Lives Globally Business
  • Bhaskar Reddy has been awarded as the most prominent industry leader 2022 Business Consulting Category by Business Mint Business
  • Innovations in Orthopedic Care: Experts Insights on Bone & Joint Day Health
  • Meet top 10 Brands Transforming Industries and Setting New Benchmarks in 2026 Business
  • Ongoing Conflict in West Asia- A matter of serious concern for MMF exporters –  Shri  Shaleen Toshniwal , Chairman, MATEXIL Business

Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants

Posted on July 11, 2022 By

Akums Drugs & Pharmaceuticals Ltd. has recently received European Union GMP approval for two of their manufacturing units in Haridwar.

New Delhi (India), July 11: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently acquired the stringent European Union (EU) GMP  approval for two of their manufacturing units in Haridwar. Following this prestigious nod, the gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs. This move is another assent to Akums’ “Quality First” approach to work, which has now been endorsed by the EU -GMP beside all top-notch Indian and multinational pharmaceutical companies, who are already Akums’ long-standing partners.

Akums has received EU GMP approval for its two manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and Another plant manufactures large volume parenteral and small volume parenterals lines, including vials, ampoules, eyedrops, FFS  as well as for dry powder injections in the penicillin line.

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain, says, “We are happy to announce that Akums Drugs has received EU GMP approval for two of our Haridwar-based manufacturing facilities, thus paving the path for new opportunities from the entire European Union as well as many other regulatory markets. We are already the largest Indian contract manufacturing company, manufacturing > 12% of country’s domestic supply, but what makes us happiest is being recognised for our “Quality First” approach. While we have been endorsed for this quality by our partners, who are also leading Indian and multinational pharmaceutical companies, the latest one from the EU GMP is very widely recognised & accepted. Congratulations to the entire team, and I hope this is the beginning of numerous possibilities for us.”

Founder, Promoter and Director Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain, says, “Akums is already exporting to over 50 countries worldwide. With the esteemed EU GMP nod, we have now gained access to the most stringent global pharmaceutical markets besides the USA. These include the entire European Union, other markets like South Africa, Canada, Malaysia, Indonesia, Thailand, Australia/New Zealand and most middle-eastern countries. Since the EU GMP is their gold standard, we are welcome to cater to the pharmaceutical demands of all these geographies. With a large R&D infrastructure already in place, we are well equipped with a good basket of Products in our pipeline to expand our presence in these regulated markets. While we are extremely proud and excited to expand our presence in these markets, the Indian domestic market has always been our pride & passion and will continue to be so. The trust our partners have in us, and our Quality is paramount for us. ”

Akums Drugs & Pharmaceuticals Ltd. is India’s largest contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s consumption. The organisation deals in manufacturing and exporting formulations in a broad spectrum of dosage forms & therapeutic segments. The company currently supplies to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer in the country. The ten state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, personal care,  Ayurvedic, food supplements & nutraceuticals and animal health care.

In a few years, the organisation has become the icon of the Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations and building trust-based on efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi, amongst others and exports to 53 countries across the world.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: KPar Smart Products Announces 1 year report on Smart Cities
Next Post: La Excellence announced the launch of its Batch-2 for students aspiring to enter into the Civil Services in Telangana on July 11

Related Posts

  • Digirestro Welcomes Nikhil Kitukale as VP of Product & Growth, Strengthening F&B Tech Solutions. Business
  • Shah Metacorp Ltd Net Profit jump to Rs. 23.27 Crore in Q1FY25 Business
  • IMS Noida organized a Road safety awareness competition Business
  • Mastertrust: Women Mastering Finances The Trusted Way Business
  • Global Pride Awards Celebrate Outstanding Achievers Across India Business
  • International Women’s Day 2023: Women-in-Health Leading the Industry & Transforming Healthcare Business

Recent Posts

  • QAD | Redzone Strengthens AI Commitment with New Pune Hub Inauguration
  • Manasi Pawar Makes a Jaw-Dropping Red Carpet Debut at the 2026 Cannes Film Festival
  • ROTORIS Names IPL-Winning Captain Rajat Patidar as ‘A ROTORIS Man’ for IPL 2026
  • German Trade Fair Leader Messe Stuttgart Strengthens Presence in India with Acquisition of ‘Cable & Wire Fair’
  • How to Protect Your Savings from Inflation: The Power of Compounding Explained

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • The Banker Media Announces Asia’s Leading Annual Summit for Urban Cooperative Banks in Lucknow Business
  • PNB MetLife Launches Dividend Leaders Index Fund: A Disciplined Way to Invest in Consistent Cash Flow Generators Finance
  • Jalpak Foods Secures Strategic Investment by Growth Investor Aditya Halwasiya Business
  • Shawario: The Tummy Section’s Avatar of Shawarma Business
  • At MicroNet, The Focus Is On High-Performance Annual Maintenance Contract Service   Business
  • Swara Group unveils major redevelopment project in Naranpura Lifestyle
  • Brahmāstra Part One: Shiva To Have A Mega Premiere On Star Gold On Sunday 26 March At 8:00 PM Business
  • Nakshatra Living : PProm’s Bungalow Township Project in Dapoli Where Your Dream Home Becomes a Reality Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme